Brief Definitive Report

Similar documents
Chapter 4 Cellular Oncogenes ~ 4.6 -

Molecular Diagnosis. Nucleic acid based testing in Oncology

Nucleic Acid Testing - Oncology. Molecular Diagnosis. Gain/Loss of Nucleic Acid. Objectives. MYCN and Neuroblastoma. Molecular Diagnosis

Chronic Myelogenous Leukemia (CML) Amplification of Rearranged c-abl Oncogenes in CML Blast Crisis

CYTOGENETICS Dr. Mary Ann Perle

Malignant lymphomas are neoplasms that arise from B

Chromosome Alterations in Oncogenesis

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Variations in Chromosome Structure & Function. Ch. 8

Haematology Probes for Multiple Myeloma

Activation of cellular proto-oncogenes to oncogenes. How was active Ras identified?

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Molecular Analysis of Rearrangements in Philadelphia (Ph 1 ) Chromosome-Positive Leukemia

( Compauson of the JJsefulness_and_CoSts of R.r.AhI Analysis yprcnc. Chromosome Analyse

Chromosome Abnormalities

Role of FISH in Hematological Cancers

Cytogenetic and Molecular Evaluation in Myelodysplastic Syndrome and in Acute and Chronic Leukemia

Structural Variation and Medical Genomics

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010

Probable involvement of immunoglobulin superfamily genes in most recurrent chromosomal rearrangements from ataxia telangiectasia

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Chromosomal Aberrations

Detection of abl/bcr Fusion Gene in Patients Affected by Chronic Myeloid Leukaemia by Dual-Colour Interphase Fluorescence in situ Hybridisation

oncogenes-and- tumour-suppressor-genes)

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays

September 04, 2008

Application. Application of molecular biology methods in hematology and oncology. Oncogenes are involved in:

LOW DOSES OF RADIATION REDUCE RISK IN VIVO

American Society of Cytopathology Core Curriculum in Molecular Biology

Determination Differentiation. determinated precursor specialized cell

Acute Promyelocytic Leukemia with i(17)(q10)

BIOL2005 WORKSHEET 2008

Course Title Form Hours subject

BIOLOGY - CLUTCH CH.15 - CHROMOSOMAL THEORY OF INHERITANCE

Gene Rearrangements in the Diagnosis of Lymphoma/Leukemia Guidelines for Use Based on a Multiinstitutional Study

GENETIC MARKERS IN LYMPHOMA a practical overview. P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute

Molecular mechanisms of human carcinogenesis

somatic cell hybrids (DNA polymorphism/multigene family/hormonally responsive genes/southern blot analysis)

Multistep nature of cancer development. Cancer genes

Fluorescent in situ hybridization studies in multiple myeloma

The Adaptive Immune Response. T-cells

Structural Chromosome Aberrations

-19. -Mousa Salah. -Shahd Alqudah. -Dr Belal

Hematopathology Service Memorial Sloan Kettering Cancer Center, New York

BHS training course. Laboratory Hematology Cytogenetics. Lucienne Michaux. Centrum voor Menselijke Erfelijkheid, UZLeuven

Chromothripsis: A New Mechanism For Tumorigenesis? i Fellow s Conference Cheryl Carlson 6/10/2011

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU

Understanding the Human Karyotype Colleen Jackson Cook, Ph.D.

Heterogeneity of Abnormal RUNX1 Leading to Clinicopathological Variations in Childhood B-Lymphoblastic Leukemia

The Chromosomal Basis of Inheritance

An Overview of Cytogenetics. Bridget Herschap, M.D. 9/23/2013

ACMG/CAP Cytogenetics CY

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies

Introduction. Introduction. Lymphocyte development (maturation)

Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?

Lecture 17: Human Genetics. I. Types of Genetic Disorders. A. Single gene disorders

Volume 7, Issue 1 January 2012

Introduction to Cancer Biology

CNV Detection and Interpretation in Genomic Data

An International System for Human Cytogenetic Nomenclature (2013)

Cytogenetic and Molecular Changes in Leukemia Found. among Atomic Bomb Survivors

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Reporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota

Origin of oncogenes? Oncogenes and Proto-oncogenes. Jekyll and Hyde. Oncogene hypothesis. Retroviral oncogenes and cell proto-oncogenes

Chronic Lymphocytic Leukemia (CLL)

Chapter 11 Patterns of Chromosomal Inheritance

The Chromosomal Basis of Inheritance

Course Curriculum for Master Degree in Medical Laboratory Sciences / Diagnostic Molecular Biology and Human Genetics

Genomic Instability. Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute. RPN-530 Oncology for Scientist-I October 18, 2016

Cancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?

Recommended Timing for Transplant Consultation

Introduction to Genetics

Generation of antibody diversity October 18, Ram Savan

Cancer genetics, cytogenetics defining the enemy within

Use of MYC, BCL2 and BCL6 FISH for investigations of high grade B cell lymphoma

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser

Mohammed El-Khateeb. Tumor Genetics. MGL-12 May 13 th Chapter 22 slide 1 台大農藝系遺傳學

Methods used to diagnose lymphomas

HEMATOPATHOLOGY SUMMARY REPORT RL;MMR;

Chapter 16 Mutations. Practice Questions:

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)

The mutations that drive cancer. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

Chromosome Structure & Recombination

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Test Name Results Units Bio. Ref. Interval. Positive

MYC Translocations In Multiple Myeloma Involve Recruitment Of Enhancer Elements Resulting In Over- Expression and Decreased Overall Survival

XIII. Molecular pathogenesis of transformed lymphomas

Prepared by: Dr.Mansour Al-Yazji

ONE STEP MULTIPLEX RT-PCR FOR BCRlABL GENE IN MALAY PATIENTS DIAGNOSED AS LEUKAEMIA

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Corrigenda. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (revised 4th edition): corrections made in second print run

THE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNANCIES

Analysis of individual differences in radiosensitivity using genome editing

RAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.

Andrea s SI Session PCB Practice Test Test 3

Chronic myeloid leukemia (CML)

ADVANCES IN CHILDHOOD ACUTE LEUKEMIAS : GENERAL OVERVIEW

Transcription:

Brief Definitive Report T CELL RECEPTOR a CHAIN GENES ARE LOCATED ON CHROMOSOME 14 AT 14q11-14q12 IN HUMANS BY NICOLETTE CACCIA, GAIL A. P. BRUNS,* ILAN R. KIRSCH,* GREGORY F. HOLLIS,* VIRGINIA BERTNESS,* and TAK W. MAK From the Department of Medical Biophysics, University of Toronto, Ontario Cancer Institute, Toronto, Canada M4X 1K9; the *Children's Hospital, Boston, Massachusetts 02115; and the * NCI-Navy Medical Oncology Branch, National Naval Medical Center, Bethesda, Maryland 20814 The mammalian immune system uses a number of different cell types to defend the body against a wide variety of foreign antigens. T iymphocytes play an important role in this defense, participating in a number of cell-cell interactions that control differentiation and regulation of the immune response. The recognition of antigen by T cells is mediated by the T cell antigen receptor, a cell surface protein dimer, composed of disulfide-linked a and/3 chains (1). In the past year, human cdnas encoding these chains have been isolated (1, 2). These structures show extensive similarity to immunoglobulin at the protein level (1, 2). The/3 chain genes, which were isolated first and have been studied in more depth, undergo somatic rearrangement in T cells and have a genomic organization similar to that of immunoglobulin (1). Based on the assumption that the a chain genes belong to the immunoglobulin supergene family, one would expect similar results for these genes. The determination of chromosomal location of the T cell receptor genes is important for a number of reasons, including the establishment of linkage groups. The location of T cell receptor genes with respect to other immune system genes, such as the immunoglobulin and major histocompatibility complex (MHC) loci, may provide information as to the evolution of this family. More importantly, the possible involvement of these genes in chromosomal abnormalities can be determined by these studies. A substantial body of evidence indicates that specific chromosomal abnormalities play an important role in the genesis of certain human and animal tumors. In a number of chromosomal translocations, cellular homologues of retroviral transforming genes are located near the breakpoints, suggesting that tumorigenesis can occur by the activation of these genes. Much of the evidence for this has come from lymphoid neoplasias. Chronic myelogenous leukemia (CML) is characterized by the Philadelphia chromosome, which is the product of a translocation between chromosomes 9 and 22 that results in the amplification of the cellular homologue of the oncogene, abl, and increases its level of expression (3). In addition, the immunoglobulin loci in both man and mouse have been shown (4) to be involved in the activation of the cellular homolog of myc, resulting in B cell tumorigenesis. This suggests the possibility of j. ExP. MED. The Rockefeller University Press 0022-1007/85/05/1255/06 $1.00 Volume 161 May 1985 1255-1260 1255

1256 CACCIA ET AL. BRIEF DEFINITIVE REPORT a similar mechanism of activation of inappropriate genes by the T cell receptor loci in T cell neoplasia. Materials and Methods Somatic Cell Hybrids. The somatic cell hybrids used for the mapping panels were described previously (5). They were derived from fusion of hypoxanthine phoshoribosyl transferase-deficient mouse cell RAG or Chinese hamster cell E36 with fibroblasts or white blood cells (WBC) from four individuals. The two WBC donors were female carries of reciprocal X]19 translocation chromosomes: the X/19W translocation t(x;19)(q23-25::q 13) (6) and the X/19B translocation t(x; 19)(q 1 ::pl 3). One of the fibroblast donors was a normal male and the second was a female carrier of a reciprocal X/13 translocation t(x;13) (q21-23::q21-31) (6). The hybrid clones were characterized by analysis of isozymes characteristic of each human chromosome and by cytogenetic techniques. In addition, cloned DNA probes were used to monitor twenty of the human autosomes and the X chromosome in the DNAs of the mapping panels. Hybridization. Southern blots were performed essentially as described previously (5). Filters were prehybridized 4 h, then hybridized to a nick-translated probe consisting of a 389 basepair PvuII/PvuII constant region fragment from py14 ~ for 20 h. The filters were washed at 65 C in 0.5x standard sodium citrate/0.1% sodium dodecyl sulfate and exposed to Kodak XAR-5 film for 4-14 d in the presence of intensifying screens. In Situ Hybridization. In situ hybridization was performed as described previously (8), using py1.4 as a probe. 64 human peripheral blood cells containing a total of 140 silver grains were analyzed. Results Using a cdna clone, py 14 ~, we determined the chromosomal location of the human T cell receptor a chain gene family by Southern blot analysis of DNA isolated from 17 human-hamster and eight human-mouse somatic cell hybrid cell lines. DNA derived from these hybrids was digested with EcoRI and hybridized to a human C~ probe isolated from py14. A representative blot is shown in Fig. 1. In all cases, hybridization to homologous hamster (5.1 kilobase [kb]) or mouse (4.8 kb) sequences could be detected, in addition to the 16 kb human-specific band. Eight human-hamster and two human-mouse hybrids were also analyzed with two other restriction endonucleases, BamHI and HindIII, to confirm the results found using EcoRI. As shown in Table I, the pattern of hybridization to human-specific restriction fragments maps the T cell receptor o~ chain unambiguously to chromosome 14. FIGURE 1. Hybridization of a human Ca probe to human-rodent hybrid cell lines. EcoRIdigested DNA from the cell lines was annealed to the 389 basepair Ca probe derived from py14 ~. (a) HeLa cell DNA; (b) E36, the hamster parent; (c) RAG, the mouse parent; (d,f, h- m) human-hamster hybrids G35F3, G35F1, G35D2, G35A4, G35C4, G35A2, G35F5, and G35F3, respectively; (e, g) human-mouse hybrids G24B5 and G46C2, respectively.

CACC1A ET AL. BRIEF DEFINITIVE REPORT 1257 + + + + + 1 1 + + 1 1 + + + 1 + 1 + 1 1 1 1 + 1 + I I I I I I I I I I I I I I I I I l l l l + l l + Zl~ + + + + + + + + + + + + + + + + + + + + + + + + + + 1 + + 1 + 1 + 1 + + + + + 1 1 1 + + II+I + + + + + 1 1 1 + 1 + 1 1 + 1 + 1 + + + 1 1 + + 1 + 1 + + + + 1 + 1 + + + ++II I+I+ E + + + + + + + + + + + + I +++++ ~* I I ~ I'I- I l I I + I -I-~ 4- I * 4-"I- I +-I-+ ++ I* ~E I I I I I + I I I ++ I I I I I + ~ I + I + I I + I +++ I + I I ++ + I +* +III Zl~.3 + + I I I I I + I + I + + I + I I I + + + + + I I + + I * + + + I + I + ++II I+I+ * + + I I I + I I I I + + + I I I + + I I z z "I~ +* +I I +++++I I++I ++I I ++ + o o +I ++I +++I+I I I+ I I++ I ++ I ~'I~ "4 +I+ I I+ I +I I++I I I++ I+ ++ I I+ I I I~++ I~I~I I + ++ + II I -~I~, 0 ~ 1 I I+ I I I I I+1 I+1 ++1 I+ + -~I~ + + + 1 1 1 + + 1 1 + + * 1 1 1 + 1 ++ + ~I~ + + 1 + + 1 ~ + + 1 + 1 + 1 1 1 + +1 I "I~ + + 1 1 1 + 1 1 + + 1 1 1 + 1 + + 1 +1 + -~I~ + 1 + + + 1 1 + 1 1 1 1 1 1 ~ + 1 + + 1 + + + 1 1 ~ 1 1 1 + 1 1 1 1 + + +++1 ~I~ + + 1 1 1 1 1 1 1 1 + + 1 1 1 + 1 ++11 --I~ + + + 1 + + 1 1 1 + 1 + 1 1 1. 1 + ++1+ "I~ I Q.;2 ~0 +'~

1258 CACCIA ET AL. BRIEF DEFINITIVE REPORT 20 f ~...,.I E t0.1.010 p I' i01' 6 7,10 i ll 112 o 7; foto 1 I.,..., Chromosome Number FIGURE 2. In situ hybridization to a human C, probe. The distribution of 140 silver grains over metaphase chromosomes obtained from an analysis of 64 cells is shown. A significant accumulation of grains is noted over the proximal region of the long arm of chromosome 14, bands 14ql.l-14ql.2. To further localize these genes, in situ hybridization was performed, using human peripheral blood cells and a human, probe isolated from py1.4. The distribution of the 140 grains scored is shown in Fig. 2. 18 of these grains were found at bands 14ql. 1-1.2 (in 14 of the 64 cells), confirming our results obtained from the somatic cell hybrids and mapping the 0~ chain locus to this position in humans. Discussion The assignment of the T cell receptor a chain genes to position 14q 11-14q 12 in humans poses some interesting questions. Abnormalities of this chromosome are involved in a number of T cell-related disorders, including chronic lymphocytic leukemia (CLL) (8, 9), childhood acute lymphoblastic leukemia (10) and adult T cell leukemia (11-13). Chromosome 14 abnormalities are also found in patients with ataxia telangiectasia (AT), a rare autosomal recessive disease, which is characterized by strong predispositions towards immunodeficiency, chromosomal instability, and neoplasia, especially of lymphoid origin (14). There is nonrandom involvement of both chromosome 7, where the T cell receptor /3 chain genes are located (5), and chromosome 14, which contains the immunoglobulin heavy chain locus at the distal end of the long arms (15), as well as the a chain genes at the proximal end of the same arm. The most common abnormality is a tandem translocation between these two portions of 14q (14, 16). It has been postulated (17) that there is a DNA repair defect in AT (17). This would partially explain these chromosomal abnormalities as products of aberrant repair of T cell receptor and immunoglobulin heavy chain rearrangement, and would provide a basis for immunodeficiency and the increased rate of lymphoid neoplasia. It has been suggested (14) that the creation of a 14q + chromosome provides a proliferative advantage to lymphoid cells (14). This is supported by the finding that, in a

CACC1A ET AL. BRIEF DEFINITIVE REPORT 1259 number of cases, the malignant cells in T cell leukemia of AT patients retain the 14q + marker, but lose the 14q- marker (14). In T cell CLL, an inversion of the long arm of chromosome 14 between the proximal and distal regions has been reported in a number of cases (8, 18). In patients with ATL, there are chromosomal abnormalities involving both chromosome 7 (11) and 14 (11-13), lending support to the hypothesis that T cell receptor genes may be involved in tumorigenesis. The common feature of the abnormalities in these T cell disorders is a rearrangement of the proximal region of 14q (18). Although chromosome 14 is also involved in B cell neoplasias, the break usually involves the distal end of the long arm, most frequently band q32, where the heavy chain immunoglobulin genes are located (19). This correlation of break location and cell type involvement in lymphoid neoplasia has led researchers to propose (16, 18) that the proximal region of 14q, near q l 1, contains genes that are important in T cell function. Our results indicate that the T cell receptor a chain genes are contained within this region and may be involved in these abnormalities. If this is the case, a number of avenues of investigation will be opened. The role of the a chain locus in the development of these tumors can be explored and the molecular mechanisms involved in their development studied. Summary A cdna clone encoding the ~ chain of the human T cell receptor was used in connection with somatic cell human-rodent hybrids to determine that the genes coding for the a chain are located on chromosome 14 in humans. In situ hybridization confirms this result and further localizes these genes to 14ql 1-14q 12 on this chromosome. Since this region of chromosome has been shown to be nonrandomly involved in a number of T cell neoplasias, this assignment raises a number of interesting questions as to the possible involvement of the T cell receptor a chain genes in tumorigenesis. Received for publication 15 February 1985. References 1. G. M611er, editor. 1984. T Cell Receptors and Genes. Immunol. Rev. Vol, 81. 2. Yanagi, Y., A. Chan, B. Chin, M. Minden, and T. W. Mak. Analysis of cdna clones specific for human T cells and the a and 13 chains of the T cell receptor heterodimer from a human T cell line. Proc. Natl. Acad. Sci. USA. In press. 3. Groffen, J., J. R. Stephenson, N. Heisterkamp, C. Bartram, A. de Klein, and G. Grosveld. 1984. The human c-abl oncogene in the Philadelphia translocation. In Cellular & Molecular Biology of Neoplasia. T. W. Mak and I. Tannock, editors. Alan R. Liss, Inc., Ne W York. 179-181. 4. Caccia, N., T. W. Mak, and G. Klein. 1984. c-myc Involvement in chromosomal translocations in mice and men. In Cellular & Molecular Biology of Neoplasia. T. W. Mak and I. Tannock, editors. Alan R. Liss, Inc., New York. 199-208. 5. Caccia, N., M. Kronenberg, D. Saxe, R. Haars, G. A. P. Bruns, J. Goverman, M. Malissen, H. Willard, Y. Yoshikai, M. Simon, L. Hood, and T. W. Mak. 1984. The

1260 CACCIA ET AL. BRIEF DEFINITIVE REPORT T cell receptor B chain genes are located on chromosome 6 in mice and chromosome 7 in humans. Cell. 37:1091. 6. Latt, S. A., H. F. Willard, and P. S. Gerald. 1976. BrdU-22358 Hoechst analysis of DNA replication in human lymphocytes with supernumerary or structurally abnormal X chromosomes. Chromosome (Berl). 57:135. 7. Kirsch, I. R., C. C. Morton, K. Nakahara, and P. Leder. 1982. Human immunoglobulin heavy chain genes map to a region of translocations in malignant B lymphocytes. Science (Wash. DC). 216:301. 8. Zech, L., L. Hammarstrom, and C. I. E. Smith. 1983. Chromosomal aberrations in a case of T-cell CLL with concomitant IgA myeloma. Int. J. Cancer. 32:431. 9. Zech, L., L. Gahrton, L. Hammarstrom, G. Juliusson, H. Mellstedt, K. H. Robert, and C. I. E. Smith. 1984. Inversion of chromosome 14 marks human T-cell chronic lymphocytic leukemia. Nature (Lond.). 308:858. 10. Williams, D. L., A. T. Look, S. L. Melvin, P. K. Roberson, G. Dahl, T. Flake, and S. Stass. 1984. New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell. 36:101. 11. Ueshima, Y., S. Fukuhara, T. Hattori, T. Uchiyama, K. Takatsuki, and H. Uchino. 1981. Chromosome studies in adult T-cell leukemia in Japan: significance of trisomy 7. Blood. 58:420. 12. Miyoshi, I., M. Sumita, K. Sano, R. Nishihara, K. Miyamoto, I. Kimura, andj. Sato. 1979. Marker chromosome 14q + in adult T-cell leukemia. New Engl.J. Med. 300:921. 13. Miyamoto, K., J. Sato, K. Kitajima, A. Togawa, S. Suemaru, H. Sanada, and T. Tanaka. 1983. Adult T-cell leukemia: chromosome analysis of 15 cases. Cancer. 52:471. 14. Kaiser-McCaw, B., and F. Hecht. 1983. The interrelations in ataxia telangiectasia of immune deficiency, chromosome instability and cancer. In Chromosomal Mutation and Neoplasia. J. German, editor. Alan R. Liss, Inc., New York. 193-202. 15. Croce, C. M., M. Shander, J. Martinis, L. Circurel, G. G. D'Anco, T. W. Dolby, and H. Kaprowski. 1979. Chromosomal location of the genes for human immunoglobulin heavy chains. Proc. Natl. Acad. Sci. USA. 76:3416. 16. Bernstein, R., M. Pinto, and T. Jenkins. 1981. Ataxia telangiectasia with evolution of monosomy 14 and emergence of Hodgkin's disease. Cancer Genet. Cytogenet. 4:31. 17. Chaganti, R. S. K. 1983. The significance of chromosome change to neoplastic development. In Chromosomal Mutation and Neoplasia. J. German, editor. Alan R. Liss, Inc., New York. 359-396. 18. Hecht, F., R. Morgan, R. Hecht, and S. D. Smith. 1984. Common region on chromosome 14 in T-cell leukemia and lymphoma. Science (Wash. DC). 226:1445. 19. Ueshima, Y., J. D. Rowley, D. Variakojis, J. Winter, and L. Gordon. 1984. Cytogenetic studies on patients with chronic T cell leukemia/lymphoma. Blood. 63:1028.